TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32707101

Group type: EXPERIMENTAL
Intervention: Family Check-Up 4 Health (FCU4Health) program
Number of subjects: 200

Group type: COMPARATOR
Intervention: Services as usual
Number of subjects: 200
Study: 32969563

Group type: EXPERIMENTAL
Intervention: Cabozantinib (40 mg) plus docetaxel (75 mg/m2 every 3 weeks) and prednisone (10 mg daily)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Docetaxel (75 mg/m2 every 3 weeks) and prednisone (10 mg daily) alone
Number of subjects: 44
Study: 35905636

Group type: EXPERIMENTAL
Intervention: Daily massage therapy administered by the mother from 34 weeks' to 40 weeks' corrected age (CA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 60
Study: 34293233

Group type: EXPERIMENTAL
Intervention: Esketamine plus oral antidepressant
Number of subjects: 223

Group type: COMPARATOR
Intervention: Antidepressant/placebo
Number of subjects: 223
Study: 35395557

Group type: EXPERIMENTAL
Intervention: Light intensity game-based exercise (LIG; 58.64% HRmax)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Vigorous intensity game-based exercise (VIG; 89.51% HRmax)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 37
Study: 33757566

Group type: EXPERIMENTAL
Intervention: SPRY4-IT1 expression level in esophageal cancer tissues
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: High expression of SPRY4-IT1
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Increased expression of SPRY4-IT1
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: SPRY4-IT1 expression level
Number of subjects: 92
Study: 34508886

Group type: EXPERIMENTAL
Intervention: 7-day treatment
Number of subjects: 248

Group type: COMPARATOR
Intervention: 14-day treatment
Number of subjects: 248
Study: 32388584

Group type: EXPERIMENTAL
Intervention: Enteric-coated NaHCO3 (0.3 g∙kg‐1 body mass)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Gelatin NaHCO3 (0.3 g∙kg‐1 body mass)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 36196796

Group type: EXPERIMENTAL
Intervention: Complex 1 ([Fe(L)][Fe(bpb)(CN)2]·CH3OH·0.5H2O)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Complex 2 ([Fe(L)][Co(bpb)(CN)2]·CH3OH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Complex 3 ([(Fe (L))2(4,4'‐bipy)](BPh4)2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Complex 4 ([Fe(L)(py)](BPh4))
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Complex 5 ([Fe(L)(dmap)](BPh4))
Number of subjects: 0
Study: 32954451

Group type: EXPERIMENTAL
Intervention: Cypermethrin (CYP) treatment at 10 μg mL‐1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cypermethrin (CYP) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (CK)
Number of subjects: 0
Study: 32532772

Group type: EXPERIMENTAL
Intervention: Inpatient rehabilitation (AUS 52%)
Number of subjects: 668

Group type: EXPERIMENTAL
Intervention: Community rehabilitation (UK 65%)
Number of subjects: 668

Group type: EXPERIMENTAL
Intervention: Inpatient rehabilitation then community rehabilitation
Number of subjects: 668

Group type: EXPERIMENTAL
Intervention: Home with no rehabilitation
Number of subjects: 668

Group type: EXPERIMENTAL
Intervention: Working prior to stroke (n=228)
Number of subjects: 668
Study: 33349011

Group type: EXPERIMENTAL
Intervention: Mg+H2
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Mg and Mg+H2
Number of subjects: 37
Study: 32393436

Group type: EXPERIMENTAL
Intervention: Collective navigation skills of longhorn crazy ants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Collective sensing range extension
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Percolation theory application
Number of subjects: 0
Study: 33884564

Group type: EXPERIMENTAL
Intervention: Amplatzer Amulet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Watchman/FLX
Number of subjects: 0
Study: 35224871

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) for 35 min, with intervals increasing from 50% heart rate reserve to 85–90% for 2 min.
Number of subjects: 25

Group type: COMPARATOR
Intervention: Moderate Continuous Intensity (MCI) exercise at 50% of heart rate reserve for 35 min.
Number of subjects: 25
Study: 33317345

Group type: EXPERIMENTAL
Intervention: BI 695501
Number of subjects: 317

Group type: COMPARATOR
Intervention: adalimumab RP
Number of subjects: 317
Study: 32255542

Group type: EXPERIMENTAL
Intervention: 10 mg esaxerenone
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: 40 mg esaxerenone
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: 400 mg moxifloxacin
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 35085663

Group type: EXPERIMENTAL
Intervention: Allergen immunotherapy (subcutaneous and sublingual) continued for a minimum of 3 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Grass pollen immunotherapy for seasonal rhinitis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mite sublingual immunotherapy
Number of subjects: 0
Study: 33389322

Group type: EXPERIMENTAL
Intervention: Tailored program to increase positive affect and decrease depressive symptoms
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Tailored program to increase gender empowerment
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Program delivery timing suggestion
Number of subjects: 8
Study: 33181557

Group type: EXPERIMENTAL
Intervention: Ibuprofen 10 mg·kg‐1
Number of subjects: 159

Group type: COMPARATOR
Intervention: Propacetamol 30 mg·kg‐1
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Ibuprofen 10 mg·kg‐1 + Propacetamol 30 mg·kg‐1
Number of subjects: 159
Study: 32472893

Group type: EXPERIMENTAL
Intervention: Le Fort III distraction osteogenesis without coronal incision
Number of subjects: 22

Group type: COMPARATOR
Intervention: Le Fort III distraction osteogenesis with coronal incision
Number of subjects: 22
Study: 33415472

Group type: EXPERIMENTAL
Intervention: Group Comprehensive Behavioral Intervention for Tics (group-CBIT)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Group Educational Intervention for Tics (group-EIT)
Number of subjects: 46
Study: 32232546

Group type: EXPERIMENTAL
Intervention: High dairy intake (HD) (≥ 4 servings/day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Adequate dairy intake (AD) (≤ 2 servings/day)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High dairy intake (HD)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Predictive GM signature
Number of subjects: 10
Study: 32787932

Group type: EXPERIMENTAL
Intervention: Group Interpersonal Therapy (IPT) adapted for adolescents; delivered in secondary schools by school nurses and lay community members; includes parental engagement components and locally acceptable terms for mental illness.
Number of subjects: 126
Study: 35546458

Group type: EXPERIMENTAL
Intervention: Coconut cream 50%
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clobetasol propionate 0.05% ointment
Number of subjects: 60
Study: 34247834

Group type: COMPARATOR
Intervention: Real world data as a comparator for single-arm treatment trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: External controls
Number of subjects: 0
Study: 35230052

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32130065

Group type: EXPERIMENTAL
Intervention: Gaze at the face and neck areas of each image for 10 seconds
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Attention directed toward the eye
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Attention directed toward the nose
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Attention directed toward the cheek
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Attention directed toward the neck
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Attention directed toward the mouth
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Attention within the eye‐nose‐cheek triangle
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Attention within the eye‐nose‐mouth triangle
Number of subjects: 80
Study: 34806331

Group type: EXPERIMENTAL
Intervention: Progesterone soft capsule under fasting conditions
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Progesterone soft capsule under fed conditions (high-fat meal, 890 kcal)
Number of subjects: 96
Study: 33271398

Group type: EXPERIMENTAL
Intervention: Violent game player
Number of subjects: 192

Group type: COMPARATOR
Intervention: Violent game observer
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Neutral game player
Number of subjects: 192

Group type: COMPARATOR
Intervention: Neutral game observer
Number of subjects: 192
Study: 35779136

Group type: EXPERIMENTAL
Intervention: High diet (20% crude protein, 67.9% total digestible nutrients)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Medium diet (17% crude protein, 66% total digestible nutrients)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Low diet (12.2% crude protein, 62.9% total digestible nutrients)
Number of subjects: 9
Study: 34626515

Group type: EXPERIMENTAL
Intervention: Bortezomib (Btz) in combination with melphalan and prednisolone (MPB)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: HLA-B*40:06
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: HLA-B*40:06 and HLA-DRB1*12:01
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: HLA-DRB1*08:02
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: HLA-DQB1*03:02, HLA-DQB1*05:01, and HLA-DRB1*01:01
Number of subjects: 82
Study: 35121396

Group type: EXPERIMENTAL
Intervention: Anatomic‐RPA group M1a (no co‐existing liver‐bone metastases)
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Anatomic‐RPA group M1b (co‐existing liver‐bone metastases)
Number of subjects: 183
Study: 33947873

Group type: EXPERIMENTAL
Intervention: BD‐II patients (n=149)
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Composite probability score based on five proteins in training group
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Composite probability score based on five proteins in testing group
Number of subjects: 371
Study: 33066974

Group type: EXPERIMENTAL
Intervention: SSRI exposure (fluoxetine, sertraline, escitalopram/citalopram)
Number of subjects: 1228

Group type: EXPERIMENTAL
Intervention: Fluoxetine exposure
Number of subjects: 1228

Group type: EXPERIMENTAL
Intervention: SSRI exposure
Number of subjects: 1228
Study: 36194057

Group type: EXPERIMENTAL
Intervention: AlloDerm
Number of subjects: 128

Group type: COMPARATOR
Intervention: DermaMatrix
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: AlloDerm and DermaMatrix
Number of subjects: 128
Study: 34043621

Group type: EXPERIMENTAL
Intervention: Mosquito Exposure Index (MEI) measured by ELISA for anti-Aedes saliva antibodies
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Mosquito Exposure Index (MEI) for indoor Aedes densities
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Individual characteristics influencing MEI
Number of subjects: 360

Group type: COMPARATOR
Intervention: Correlation between MEI and DENV-infected Aedes
Number of subjects: 360
Study: 32236147

Group type: EXPERIMENTAL
Intervention: Nordic Walking (NW) training 3 times a week for 6 weeks
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Nordic Walking (NW) training
Number of subjects: 18

Group type: COMPARATOR
Intervention: Nordic Walking (NW)
Number of subjects: 18
Study: 35933340

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Response-adaptive randomisation
Number of subjects: 0
Study: 33118433

Group type: EXPERIMENTAL
Intervention: TEVAR with a bare stent
Number of subjects: 84

Group type: COMPARATOR
Intervention: TEVAR only
Number of subjects: 84
Study: 32182219

Group type: EXPERIMENTAL
Intervention: VRC01 infusion
Number of subjects: 18
Study: 36429728

Group type: EXPERIMENTAL
Intervention: Progressive sandbag exercise training (0.5 kg to 1 kg over 12 weeks)
Number of subjects: 40
Study: 34170841

Group type: EXPERIMENTAL
Intervention: Vascular Closure Devices (VCDs)
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Intravascular VCD
Number of subjects: 604
Study: 32297352

Group type: EXPERIMENTAL
Intervention: Standard care plus 2-weekly home end-of-life and palliative care coaching by experienced community nurses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care through their hospital or outpatient clinics
Number of subjects: 0
Study: 35098823

Group type: EXPERIMENTAL
Intervention: Nintendo Wii-Fit
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Xbox Kinect
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 68
Study: 32818304

Group type: EXPERIMENTAL
Intervention: Thoracotomy
Number of subjects: 202

Group type: COMPARATOR
Intervention: Thoracoscopy
Number of subjects: 202
Study: 32833022

Group type: EXPERIMENTAL
Intervention: Smoking initiation (genetic determinants)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased smoking risk (2-fold)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BMI as a mediator
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smoking behavior
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smoking behavior (MVP data)
Number of subjects: 0
Study: 36373571

Group type: EXPERIMENTAL
Intervention: man therapy (MT)
Number of subjects: 554

Group type: COMPARATOR
Intervention: Healthy Men Michigan (HMM)
Number of subjects: 554
Study: 34007070

Group type: EXPERIMENTAL
Intervention: CoVLP + AS03
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: CoVLP + CpG1018
Number of subjects: 180

Group type: COMPARATOR
Intervention: CoVLP (3.75 μg, 7.5 μg, and 15 μg)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: CoVLP
Number of subjects: 180
Study: 32568399

Group type: EXPERIMENTAL
Intervention: Escitalopram oxalate (n = 162)
Number of subjects: 518

Group type: EXPERIMENTAL
Intervention: Sertraline hydrochloride (n = 176)
Number of subjects: 518

Group type: EXPERIMENTAL
Intervention: Extended-release venlafaxine hydrochloride (n = 180)
Number of subjects: 518

Group type: EXPERIMENTAL
Intervention: Machine learning model using EEG and baseline symptom features
Number of subjects: 518
Study: 34902651

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Second-generation antipsychotics
Number of subjects: 0
Study: 35535982

Group type: EXPERIMENTAL
Intervention: Machine analysis of resting Doppler waveform using deep neural networks
Number of subjects: 3432

Group type: EXPERIMENTAL
Intervention: Machine analysis of resting Doppler waveform using deep neural networks (validation dataset)
Number of subjects: 3432
Study: 33386332

Group type: EXPERIMENTAL
Intervention: 2 doses of 9vHPV vaccine (0, 6 regimen)
Number of subjects: 1150

Group type: EXPERIMENTAL
Intervention: 2 doses of 9vHPV vaccine (0, 12 regimen)
Number of subjects: 1150

Group type: EXPERIMENTAL
Intervention: 3 doses of 9vHPV vaccine (0, 2, 6 regimen)
Number of subjects: 1150
Study: 32269109

Group type: EXPERIMENTAL
Intervention: Scrambler therapy
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 22
Study: 33636356

Group type: EXPERIMENTAL
Intervention: Normal Saline Solution (NSS)
Number of subjects: 540

Group type: COMPARATOR
Intervention: Savlon Solution
Number of subjects: 540
Study: 35575284

Group type: EXPERIMENTAL
Intervention: Hochuekkito administration
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control (non-hochuekkito administration)
Number of subjects: 42
Study: 33724513

Group type: EXPERIMENTAL
Intervention: Experimental arm (specific treatment not detailed)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care arm
Number of subjects: 0
Study: 32259266

Group type: EXPERIMENTAL
Intervention: 4% aqueous chlorhexidine
Number of subjects: 7820

Group type: COMPARATOR
Intervention: 10% povidone-iodine
Number of subjects: 7820

Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine in 70% isopropyl alcohol
Number of subjects: 7820

Group type: COMPARATOR
Intervention: 0.7% iodine povacrylex in 74% isopropyl alcohol
Number of subjects: 7820

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 7820
Study: 36370817

Group type: EXPERIMENTAL
Intervention: Higher recirculation air rates in fully occupied cabins
Number of subjects: 559

Group type: EXPERIMENTAL
Intervention: Higher recirculation air rates in half-occupied cabins
Number of subjects: 559

Group type: COMPARATOR
Intervention: Half-occupied cabin
Number of subjects: 559

Group type: COMPARATOR
Intervention: Fully occupied cabin
Number of subjects: 559
Study: 33253833

Group type: EXPERIMENTAL
Intervention: Ixekizumab (IXE) 80 mg every 2 weeks
Number of subjects: 1346

Group type: EXPERIMENTAL
Intervention: Ixekizumab (IXE) 80 mg every 4 weeks
Number of subjects: 1346

Group type: EXPERIMENTAL
Intervention: Ixekizumab (IXE)
Number of subjects: 1346
Study: 32127061

Group type: EXPERIMENTAL
Intervention: MTHFR 677TT genotype in male smokers
Number of subjects: 788

Group type: EXPERIMENTAL
Intervention: MTHFR 677TT genotype in nonsmokers
Number of subjects: 788

Group type: EXPERIMENTAL
Intervention: Participants >50 years with MTHFR 677TT genotype
Number of subjects: 788

Group type: EXPERIMENTAL
Intervention: Participants in the 3rd tHcy tertile
Number of subjects: 788

Group type: EXPERIMENTAL
Intervention: Participants >50 years with EGRAC
Number of subjects: 788

Group type: EXPERIMENTAL
Intervention: Moderately elevated tHcy and MTHFR 677CT genotype
Number of subjects: 788
Study: 36307361

Group type: EXPERIMENTAL
Intervention: Botulinum Toxin A (BTA) - 50 units injected twice, 3 months apart
Number of subjects: 75
Study: 34169543

Group type: EXPERIMENTAL
Intervention: AUC estimated from trough-only data using derived volume of distribution (Vd) equation: Vd (L) = 0.29(age) + 0.33(total BW in kg) + 11
Number of subjects: 4343

Group type: COMPARATOR
Intervention: Other general adult Vd models
Number of subjects: 4343
Study: 32792425

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) rapid test‐based prediction rule
Number of subjects: 7245

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 7245
Study: 36066588

Group type: EXPERIMENTAL
Intervention: Introspective writing task (IG)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Not-introspective writing task (CG)
Number of subjects: 29
Study: 34706949

Group type: EXPERIMENTAL
Intervention: Implanted CRT defibrillator with AV delay fixed at 120 ms
Number of subjects: 741

Group type: EXPERIMENTAL
Intervention: Implanted CRT defibrillator with echocardiography-determined AV delay
Number of subjects: 741

Group type: EXPERIMENTAL
Intervention: Implanted CRT defibrillator with SmartDelay algorithm-programmed AV delay
Number of subjects: 741

Group type: EXPERIMENTAL
Intervention: Overall CRT response for women versus men
Number of subjects: 741

Group type: EXPERIMENTAL
Intervention: Average treatment effect of CRT response
Number of subjects: 741

Group type: EXPERIMENTAL
Intervention: Logistic regression results after removing colliders
Number of subjects: 741
Study: 32628039

Group type: EXPERIMENTAL
Intervention: Capillary microsampling of 15 μl whole blood from fingersticks or heelsticks in a mebendazole study
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Capillary microsampling of 15 μl whole blood from fingersticks or heelsticks in a respiratory syncytial virus drug study
Number of subjects: 0
Study: 35075097

Group type: EXPERIMENTAL
Intervention: Diluted processed honey
Number of subjects: 28

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 28
Study: 33888233

Group type: EXPERIMENTAL
Intervention: MitraClip treatment
Number of subjects: 250
Study: 35803625

Group type: EXPERIMENTAL
Intervention: Higher oxygen saturation limit (≥95%)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Lower oxygen saturation limit (≥90%)
Number of subjects: 198
Study: 34861685

Group type: EXPERIMENTAL
Intervention: Granulox therapy twice weekly
Number of subjects: 79

Group type: COMPARATOR
Intervention: Standard of care (once-weekly podiatric medical clinic visits)
Number of subjects: 79
Study: 35837815

Group type: EXPERIMENTAL
Intervention: Caregiver Support Intervention (CSI)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 480
Study: 32574138

Group type: EXPERIMENTAL
Intervention: Vaccination coverage for BCG, DTP, MMR, and HepB
Number of subjects: 3600

Group type: EXPERIMENTAL
Intervention: Urban area vaccination uptake
Number of subjects: 3600

Group type: EXPERIMENTAL
Intervention: Caregiver concerns for MMR vaccine
Number of subjects: 3600

Group type: EXPERIMENTAL
Intervention: Overall vaccination status
Number of subjects: 3600

Group type: EXPERIMENTAL
Intervention: Sustainability in supply and schedule
Number of subjects: 3600
Study: 32418011

Group type: EXPERIMENTAL
Intervention: Leukocyte- and platelet-rich fibrin (LPRF)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Bio-Gide® (BG)
Number of subjects: 44
Study: 33950263

Group type: EXPERIMENTAL
Intervention: Conditioned Pain Modulation (CPM) efficiency
Number of subjects: 39
Study: 32718898

Group type: EXPERIMENTAL
Intervention: Alfieri technique
Number of subjects: 48

Group type: COMPARATOR
Intervention: Cutting technique
Number of subjects: 48
Study: 34766584

Group type: EXPERIMENTAL
Intervention: ABM + Normal intervention
Number of subjects: 43

Group type: COMPARATOR
Intervention: Normal intervention only
Number of subjects: 43
Study: 35982101

Group type: COMPARATOR
Intervention: Ultrasound group
Number of subjects: 90

Group type: COMPARATOR
Intervention: Experience group
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Control group
Number of subjects: 90
Study: 34175675

Group type: EXPERIMENTAL
Intervention: Trifluridine/tipiracil (FTD/TPI)
Number of subjects: 511
Study: 34615511

Group type: EXPERIMENTAL
Intervention: Pro‐Argin™
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: 8% strontium acetate
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: FCPS
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Sodium fluoride-based OTC dentifrices
Number of subjects: 140
Study: 32400227

Group type: EXPERIMENTAL
Intervention: No past month drug use
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Higher anger scores
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Greater emotional support
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Psychological frailty
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Minor family conflicts
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Higher positive social interaction score
Number of subjects: 130
Study: 36109420

Group type: EXPERIMENTAL
Intervention: Promoting First Relationships® (PFR) intervention
Number of subjects: 17